Additionally, patients aged 65 and older with squamous CC show a higher frequency of PIK3CA mutations, which are associated with increased mutation rates in other genes involved in key cancer-associated pathways, such as tyrosine kinase receptors, K-Ras/BRAF/MAPK and the Wnt/β-catenin pathway [102]. Here, BRAF is linked to cancer.